Results 51 to 60 of about 62,885 (295)
Equine Veterinary Education, EarlyView.Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess +5 more
wiley +1 more source
Feline hypersomatotropism and acromegaly tumorigenesis: a potential role for the AIP gene [PDF]
, 2017 Acromegaly in humans is usually sporadic, however up to 20% of familial isolated pituitary adenomas are caused by germline sequence variants of the aryl-hydrocarbon-receptor interacting protein (AIP) gene.
Catchpole, B +5 more
core +2 more sources
Dermatologic Features of Endocrine Tumor Syndromes—Systematic Review and Meta‐Analysis
International Journal of Dermatology, EarlyView.ABSTRACT Endocrine tumor syndromes, including multiple endocrine neoplasia types 1, 2A, and 2B (MEN1, MEN2A, MEN2B), Carney complex (CNC), and PTEN hamartoma tumor syndrome (PHTS), are hereditary conditions characterized by multisystem tumor development.
Sára Pálla +8 more
wiley +1 more source
Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion [PDF]
, 1989 We investigated the molecular size of circulating immunoreactive ACTH by gel chromatography in patients with ACTH hypersecretion due to various disorders of the hypothalamic-pituitary-adrenal axis.
A Chatelain +19 more
core +1 more source
Pancreatic Neuroendocrine Tumor Leading to a Diagnosis of Multiple Endocrine Neoplasia Type 1
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Pancreatic neuroendocrine neoplasms are rare but occasionally encountered. They are generally highly vascularized solid tumors, often round in shape with clear boundaries, defined contours, and a homogeneous internal structure. However, they can also present with atypical features, such as cystic degeneration, hemorrhage, calcification, and ...
Noriyuki Hirakawa +9 more
wiley +1 more source
Tumor Biology, 2017 Growth hormone–secreting pituitary adenoma accounts for about 20% of the third most common intracranial neoplasm—pituitary adenomas—which makes up 15% of all intracranial tumors.
Jianpeng Wang +6 more
doaj +1 more source
A unique coexistence of a plurihormonal pituitary adenoma with granulomatous hypophysitis
Indian Journal of Pathology and Microbiology, 2023 Dual pathology in the pituitary gland is a unique phenomenon. Coexistence of a pituitary adenoma with primary hypophysitis has been reported rarely with very few cases in the literature.
Sanjiban Patra, Priti Trivedi
doaj +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Background and aims Traditional two‐dimensional (2D) gastrointestinal endoscopy lacks depth perception, leading to potential diagnostic errors. This study evaluates a novel software‐based three‐dimensional (3D) endoscopy system that converts 2D images into 3D, compatible with existing endoscopes.
Xiaoqing Lin +22 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Primary hyperparathyroidism (PHPT) is uncommon in the pediatric population and rarely presents with overt skeletal complications such as brown tumors. This case study describes a 16‐year‐old female who initially presented with abdominal pain and was subsequently found to have severe hypercalcemia (serum calcium 16.4 mg/dL) and markedly ...
Dosti Regmi +4 more
wiley +1 more source
Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells
Endocrinology, Diabetes & Metabolism Case Reports, 2019 A 67-year-old woman with a past history of type 2 diabetes mellitus presented with worsening glycemic control. She had some acromegaly symptoms and magnetic resonance imaging demonstrated a pituitary tumor.
Shinichiro Teramoto +5 more
doaj +1 more source